We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. 15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer

    Background

    An informed decision regarding a treatment option requires data on its long-term efficacy and side-effect profile. While the side-effects...

    Akshay Sood, Ralph Grauer, ... Mani Menon in Prostate Cancer and Prostatic Diseases
    Article 04 May 2023
  2. Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma

    Background

    The increasing number of sequential treatments complicates the evaluation of overall survival (OS) in clinical trials for hepatocellular...

    Yuzhi **, Hui Ren, ... Peng Zhao in BMC Cancer
    Article Open access 23 February 2024
  3. Breast cancer patients enrolled in the Swiss mammography screening program “donna” demonstrate prolonged survival

    Study goal

    We compared the survival rates of women with breast cancer (BC) detected within versus outside the mammography screening program (MSP)...

    David Kuklinski, Marcel Blum, ... Rudolf Morant in Breast Cancer Research
    Article Open access 27 May 2024
  4. Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization

    Background

    The late presentation and diagnosis of OSCC account for the large number of patients with the advanced form of the disease. In Sudan, cases...

    Yousif Eltohami, Ahmed Suleiman in BMC Cancer
    Article Open access 15 April 2024
  5. Comparison of five-year survival rates among patients with oral squamous cell carcinoma with and without association with syphilis: a retrospective case-control study

    Background

    Syphilis is an infectious disease that is at least discussed to be premalignant. This potential, combined with its general pathological...

    Moritz Hertel, Leonie Hagedorn, ... Saskia Preissner in BMC Cancer
    Article Open access 26 April 2022
  6. Overall survival of patients with thyroid cancer in Martinique (2008–2018)

    Background

    Thyroid cancer (TC) overall survival at 5 years was estimated at 97% in mainland France over 2010–2015. Its prognosis is known to be...

    Lyvio Lin, Thierry Almont, ... Clarisse Joachim in BMC Cancer
    Article Open access 10 August 2023
  7. dsSurvival 2.0: privacy enhancing survival curves for survival models in the federated DataSHIELD analysis system

    Objective

    Survival models are used extensively in biomedical sciences, where they allow the investigation of the effect of exposures on health...

    Soumya Banerjee, Tom R. P. Bishop in BMC Research Notes
    Article Open access 06 June 2023
  8. Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival

    Background

    Adult head and neck rhabdomyosarcoma (HNRMS) is an exceptionally rare malignancy, and there is a paucity of data and research dedicated to...

    Dan Zhao, Fang Zhou, ... Shaowen **ao in BMC Cancer
    Article Open access 14 March 2024
  9. Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

    Background

    Despite some therapeutic advances, improvement in survival rates of unresectable and/or metastatic pancreatic ductal adenocarcinoma (PDAC)...

    Mengjiao Fan, Guochao Deng, ... Guanghai Dai in BMC Cancer
    Article Open access 12 January 2024
  10. Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data

    Background

    When interested in studying the effect of a treatment (or other exposure) on a time-to-event outcome, the most popular approach is to...

    Elisavet Syriopoulou, Tove Wästerlid, ... Therese M.-L. Andersson in British Journal of Cancer
    Article Open access 01 September 2022
  11. Racial and socioeconomic disparities in survival improvement of eight cancers

    Background

    Many studies have characterized racial differences in cancer outcomes, demonstrating that black and Hispanic patients have lower...

    Vikram Shaw, Baoyi Zhang, ... Chao Cheng in BJC Reports
    Article Open access 11 March 2024
  12. Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma

    Objectives

    The goal of the research was to assess the quantitative relationship between median progression-free survival (PFS) and median overall...

    Meletios Dimopoulos, Pieter Sonneveld, ... Shaji Kumar in BMC Cancer
    Article Open access 29 April 2024
  13. Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma

    Background

    Neoadjuvant chemoradiotherapy (nCRT) and surgery have been recommended as the standard treatments for locally advanced esophageal squamous...

    Run-Da Lu, Zheng-Dao Wei, ... Long-Qi Chen in BMC Cancer
    Article Open access 05 February 2024
  14. Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study

    Background

    Venous thromboembolic disease (VTE) is characterized by obstruction of venous blood flow by a thrombus. Survival data, frequency of disease...

    Estefan Ramos-Isaza, Eduardo Tuta-Quintero, ... Luis F. Giraldo-Cadavid in BMC Pharmacology and Toxicology
    Article Open access 13 December 2023
  15. Breast cancer treatment and its impact on survival in Morocco: a study over a decade

    Background

    In Morocco, much progress has been made in breast cancer treatment. However, there is limited information on survival outcomes of breast...

    Hind Mrabti, Catherine Sauvaget, ... Partha Basu in BMC Cancer
    Article Open access 01 July 2024
  16. The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates

    Background

    Currently, transperineal prostate biopsy (TPB) is preferred over transrectal biopsy (TRB) because of less infectious complications and...

    Renée Hogenhout, Sebastiaan Remmers, ... Monique J. Roobol in Prostate Cancer and Prostatic Diseases
    Article 11 January 2023
  17. Epithelial ovarian cancer survival by race and ethnicity in an equal-access healthcare population

    Background

    Previous studies in the general population observed that compared with non-Hispanic White women, Pacific Islander and Black women have...

    Zhaohui L. Arter, Daniel Desmond, ... Melissa A. Merritt in British Journal of Cancer
    Article Open access 06 December 2023
  18. Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis

    Background

    Ovarian cancer is amongst one of the most commonly occurring cancers affecting women, and the leading cause of gynecologic related cancer...

    Zahra Maleki, Mohebat Vali, ... Haleh Ghaem in BMC Cancer
    Article Open access 16 June 2023
  19. Characteristics of patients with recurrent retinoblastoma: a survival analysis

    Background

    Management guidelines and corresponding survival data for patients with recurrent retinoblastoma (RB) are lacking. This study aimed to...

    Nan Li, Yi-Zhuo Wang, ... Dong-Sheng Huang in BMC Cancer
    Article Open access 04 March 2024
Did you find what you were looking for? Share feedback.